TO:
|
The
Securities Commissions in each of the Provinces of
Canada
|
1.
|
this
certificate is delivered pursuant to section 2.20 of National Instrument
54-101 Communication
with Beneficial Owners of Securities of a Reporting Issuer (“NI
54-101) and in connection with the mailing of the Corporation’s
proxy-related materials for its Annual and Special Meeting to be held on
October 2, 2008 (the “Meeting”);
|
2.
|
the
Corporation has arranged to have proxy-related materials for the Meeting
sent in compliance with NI 54-101 to all beneficial owners at least 21
days before the date fixed for the
Meeting;
|
3.
|
the
Corporation has arranged to have carried out all of the requirements of NI
54-101 in addition to those prescribed in paragraph 2 above;
and
|
4.
|
with
respect to the Meeting, the Corporation is relying upon section 2.20 of NI
54-101 to abridge the time prescribed in subsection s. 2.2(1) and 2.5(1)
of NI 54-101.
|
LORUS
THERAPEUTICS INC.
|
||
By:
|
“Elizabeth
Williams”
|
|
Elizabeth
Williams
Director
of Finance and Acting Chief Financial
Officer
|